MEDIPOST Co., Ltd. (078160.KQ)
KRW 12000.0
(-11.37%)
KRW 12000.0
(-11.37%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 5.83 Billion KRW | 90.31% |
| 2022 | 3.06 Billion KRW | 549.11% |
| 2021 | -683.26 Million KRW | 63.43% |
| 2020 | -1.86 Billion KRW | 86.77% |
| 2019 | -14.11 Billion KRW | -603.62% |
| 2018 | -2 Billion KRW | -111.26% |
| 2017 | -949.86 Million KRW | 82.3% |
| 2016 | -5.36 Billion KRW | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | -6.84 Billion KRW | -160.09% |
| 2024 Q2 | 2.85 Billion KRW | 141.69% |
| 2023 Q1 | -6.26 Billion KRW | -226.45% |
| 2023 Q2 | 3.52 Billion KRW | 156.3% |
| 2023 Q3 | -2.8 Billion KRW | -179.57% |
| 2023 Q4 | 11.38 Billion KRW | 505.59% |
| 2023 FY | 5.83 Billion KRW | 90.31% |
| 2022 Q2 | -11.38 Billion KRW | -75.29% |
| 2022 FY | 3.06 Billion KRW | 549.11% |
| 2022 Q4 | 4.95 Billion KRW | -69.03% |
| 2022 Q3 | 15.99 Billion KRW | 240.48% |
| 2022 Q1 | -6.49 Billion KRW | -239.55% |
| 2021 Q3 | -29.22 Million KRW | 0.0% |
| 2021 FY | -683.26 Million KRW | 63.43% |
| 2021 Q4 | 4.65 Billion KRW | 16028.66% |
| 2020 FY | -1.86 Billion KRW | 86.77% |
| 2019 FY | -14.11 Billion KRW | -603.62% |
| 2018 FY | -2 Billion KRW | -111.26% |
| 2017 FY | -949.86 Million KRW | 82.3% |
| 2016 FY | -5.36 Billion KRW | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| HLB Co., Ltd. | -189.07 Billion KRW | 103.089% |
| iNtRON Biotechnology, Inc. | -9.69 Billion KRW | 160.235% |
| BINEX Co., Ltd. | 4.67 Billion KRW | -25.033% |
| Bioneer Corporation | -10.58 Billion KRW | 155.162% |
| Anterogen.Co.,Ltd. | -2.84 Billion KRW | 305.572% |
| CrystalGenomics, Inc. | -48.92 Billion KRW | 111.937% |
| Helixmith Co., Ltd | -64.08 Billion KRW | 109.112% |
| Chabiotech Co.,Ltd. | -8.43 Billion KRW | 169.266% |
| Medy-Tox Inc. | 9.75 Billion KRW | 40.134% |
| Peptron, Inc. | -15.92 Billion KRW | 136.679% |
| Amicogen, Inc. | -23.28 Billion KRW | 125.076% |
| Genexine, Inc. | -66.87 Billion KRW | 108.733% |
| HLB Therapeutics Co.,Ltd. | -2.3 Billion KRW | 353.675% |
| LegoChem Biosciences, Inc. | -73.7 Billion KRW | 107.924% |
| ALTEOGEN Inc. | -3.37 Billion KRW | 273.203% |
| PharmaResearch Co., Ltd. | 76.55 Billion KRW | 92.371% |
| SillaJen, Inc. | -20.36 Billion KRW | 128.671% |
| JETEMA, Co., Ltd. | 13.96 Billion KRW | 58.184% |
| OliX Pharmaceuticals,Inc | -19.1 Billion KRW | 130.573% |
| Genomictree Inc. | -8.75 Billion KRW | 166.697% |
| MedPacto, Inc. | -35.32 Billion KRW | 116.532% |
| D&D Pharmatech | 3.93 Billion KRW | -48.457% |
| EASY BIO,Inc. | 15.54 Billion KRW | 62.429% |
| GI Innovation, Inc. | -55.49 Billion KRW | 110.523% |